1 Bellavance, D., Chua, S
Todas nuestras clnicas estn acreditadas o reacreditadas por la Superintendencia de Instituciones de Salud y cuentan con el respaldo de Achs
In clinical trials, Semaglutide GLP-1 has been studied for different durations, ranging from 16 to 68 weeks, with varying dosages
6 AttiaM
The GLP-1 receptor agonists cardiovascular benefits are believed to stem from their effects in reducing dysfunctional body fat cells, improving glycemic control, reducing blood pressure and inflammation, and perhaps improving vascular endothelial function and plaque stability
Understanding the clinical protocols, administration methods, and comparative efficacy is the key to leveraging its full potential